Loading organizations...
§ Private Profile · Or Yehuda, Tel Aviv, Israel
Medical device company. Biodegradable wireless sensors detect surgical leaks & post-op complications for better patient outcomes.
Based in Israel, Exero Medical develops biodegradable wireless sensors designed for the early detection of surgical leaks and severe postoperative complications. The medical device company focuses on improving patient outcomes by providing healthcare providers with continuous internal monitoring technology that tracks tissue healing following complex gastrointestinal procedures. Operating within the broader medtech sector, the enterprise targets hospitals and surgical centers seeking to reduce patient recovery times and lower the clinical risks associated with internal anastomotic leaks. While specific funding amounts, valuations, and employee counts remain undisclosed, the venture is financially backed by institutional investors including the Israeli Innovation Authority, Tech Council Ventures, and Longevity Venture Partners. Exero Medical was officially founded in 2018 by the medical device incubator MEDX Xelerator alongside executive leaders Erez Shor and Matan Ben David to address these critical surgical challenges.
Exero Medical has raised $12.7M across 1 funding round.
Exero Medical has raised $12.7M in total across 1 funding round.
Exero Medical has raised $12.7M in total across 1 funding round.
Exero Medical's investors include Longevity Venture Partners.
Exero Medical has raised $12.7M across 1 funding round. Most recently, it raised $12.7M Grant / Seed in February 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 13, 2025 | $12.7M Grant | Longevity Venture Partners | — | Announced |